ChemTrak raises funds for marketing:
This article was originally published in Clinica
ChemTrak, a Sunnyvale, California-based company which has a portfolio of in-home and doctor's office tests, has raised $1 million in a private financing with a further tranche of $2 million planned later in the quarter. The company plans to spend the money in continuing the roll-out of its Parent's Alert home drug-test service, a market worth a potential $165 million according to the company.
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.